Are Stroke Drugs Better Than Stents?

Online.wsj.com: By THOMAS M. BURTON, 9/18/12

Research that suggests prescription drugs are as good or better at preventing strokes than interventional procedures is prompting a range of leading doctors to recommend against carotid surgery and carotid stent implants in most patients who haven’t had stroke symptoms.

The shift has broad implications for large medical-device makers, including Abbott Laboratories, ABT +0.17% Boston Scientific Corp., BSX -0.17% Johnson & JohnsonJNJ +0.49% and Covidien Inc., COV +0.25% which all make carotid stents to open neck arteries. Some of the companies are pushing the federal Medicare program to widen stent coverage so it pays for routine carotid stent placement in people with no stroke symptoms. The move could greatly expand stent use because an estimated 100,000 or more patients would potentially be candidates for it.

The device makers’ effort is running into a heated debate among physicians over whether drug therapies to prevent stroke have surpassed stents or carotid artery surgery as the best treatment for many patients with artery blockage in the neck. Thirty-eight leading doctors in vascular medicine have written an open letter to Medicare and urged the program not to expand coverage for carotid stents. Read more

National Minority Quality Forum
Clinical Trial Engagement Network Map Childhood Obesity MapHIV Z-Atlas: Peripheral Arterial Disease Atlas Map Lung Cancer Index Z-Atlas: Chronic Kidney Disease AFIB Index Cardiometabolic Health Aliance Minority Diabetes Coalition U.S. Diabetes Index County Edition U.S. Diabetes Index Research Edition Medicare Index Medicare Index Stroke Edition About The Minority Stroke Working Group Hepatitis C Disease Index Lead Risk Index Map MRSA StrokePAD Minority Index The South Texas Diabetes Initiative Minority Stroke Consortium YouTube NMQF Videos IPAB Action Center National Health Index

© 2011 National Minority Quality Forum, Inc. All Rights Reserved.